ATNFW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.37% compare to its pairs and should correct upwards.

Stats
Today's Volume	77 054
Average Volume	0
Market Cap	1.43M
EPS	$-1.680 ( Q1 \| 2024-05-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 0
ATR14	$0.00100 (9.80%)

ATNFW 10.87%

HROWL 0.35%

HROWM -0.19%

LFLYW -17.03%

Insider Trading

Date	Person	Action	Amount	type
2023-12-28	Feldmann Marc	Buy	135 377	Common Stock
2023-12-15	Feldmann Marc	Sell	25 000	Common Stock
2023-12-15	Woody James N.	Buy	25 000	Common Stock
2023-09-04	Feldmann Marc	Buy	15 000	Non-Qualified Stock Option (right to buy)
2023-09-04	Ray Russell T	Buy	21 455	Common Stock

INSIDER POWER
91.30
Last 31 transactions
Buy: 766 364 \| Sell: 25 000

Correlation (AI algo v.1.1b): Undervalued: 0.37% $0.0102 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

CannBioRx Life Sciences Correlation

10 Most Positive Correlations
JDZG	0.851
BWIN	0.812

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CannBioRx Life Sciences Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-105 675 (0.00 %)
EPS:	$-52.60

FY	2023
Revenue:	$0
Gross Profit:	$-105 675 (0.00 %)
EPS:	$-52.60

FY	2022
Revenue:	$0
Gross Profit:	$-109 004 (0.00 %)
EPS:	$-387.19

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

CannBioRx Life Sciences Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

CannBioRx Life Sciences

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.